Zacks Research Analysts Reduce Earnings Estimates for MOH

Molina Healthcare, Inc (NYSE:MOH - Free Report) - Stock analysts at Zacks Research decreased their Q2 2025 earnings per share (EPS) estimates for shares of Molina Healthcare in a report released on Monday, July 14th. Zacks Research analyst R. Department now anticipates that the company will post earnings of $5.51 per share for the quarter, down from their previous estimate of $6.11. The consensus estimate for Molina Healthcare's current full-year earnings is $24.40 per share. Zacks Research also issued estimates for Molina Healthcare's Q3 2025 earnings at $5.72 EPS, Q4 2025 earnings at $5.04 EPS, FY2025 earnings at $22.35 EPS, Q3 2026 earnings at $5.28 EPS, Q4 2026 earnings at $6.98 EPS, FY2026 earnings at $25.24 EPS, Q1 2027 earnings at $9.24 EPS, Q2 2027 earnings at $7.59 EPS and FY2027 earnings at $28.63 EPS.

Several other analysts have also commented on MOH. Wall Street Zen lowered shares of Molina Healthcare from a "buy" rating to a "hold" rating in a research report on Sunday, June 29th. Baird R W downgraded Molina Healthcare from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 15th. Guggenheim started coverage on shares of Molina Healthcare in a report on Wednesday, April 9th. They set a "neutral" rating on the stock. Barclays decreased their price objective on shares of Molina Healthcare from $351.00 to $347.00 and set an "equal weight" rating for the company in a research report on Monday, June 9th. Finally, Mizuho set a $330.00 target price on shares of Molina Healthcare and gave the stock an "outperform" rating in a research report on Friday, July 11th. Eleven investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus price target of $347.57.

Molina Healthcare Stock Down 10.7%

Shares of NYSE:MOH traded down $21.78 during trading hours on Thursday, hitting $182.47. The company's stock had a trading volume of 3,589,203 shares, compared to its average volume of 737,443. The firm's fifty day moving average price is $281.73 and its 200 day moving average price is $300.30. Molina Healthcare has a 52 week low of $182.09 and a 52 week high of $365.23. The company has a market capitalization of $9.89 billion, a price-to-earnings ratio of 8.81, a P/E/G ratio of 0.91 and a beta of 0.55. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.63 and a quick ratio of 1.63.

Molina Healthcare (NYSE:MOH - Get Free Report) last released its quarterly earnings data on Wednesday, April 23rd. The company reported $6.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.96 by $0.12. The company had revenue of $11.15 billion during the quarter, compared to analysts' expectations of $10.86 billion. Molina Healthcare had a net margin of 2.81% and a return on equity of 28.38%. The firm's quarterly revenue was up 12.2% on a year-over-year basis. During the same period in the previous year, the company earned $5.73 EPS.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of MOH. Price T Rowe Associates Inc. MD increased its holdings in shares of Molina Healthcare by 46.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,838,043 shares of the company's stock valued at $1,264,214,000 after acquiring an additional 1,216,903 shares during the last quarter. Wellington Management Group LLP lifted its position in Molina Healthcare by 7.4% in the fourth quarter. Wellington Management Group LLP now owns 2,632,232 shares of the company's stock valued at $766,111,000 after acquiring an additional 181,073 shares during the last quarter. FMR LLC lifted its position in Molina Healthcare by 31.1% in the fourth quarter. FMR LLC now owns 1,801,113 shares of the company's stock valued at $524,214,000 after acquiring an additional 427,276 shares during the last quarter. T. Rowe Price Investment Management Inc. lifted its position in Molina Healthcare by 8.6% in the first quarter. T. Rowe Price Investment Management Inc. now owns 1,487,896 shares of the company's stock valued at $490,099,000 after acquiring an additional 117,796 shares during the last quarter. Finally, Geode Capital Management LLC lifted its position in Molina Healthcare by 2.5% in the fourth quarter. Geode Capital Management LLC now owns 1,436,909 shares of the company's stock valued at $417,144,000 after acquiring an additional 34,992 shares during the last quarter. 98.50% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, CEO Joseph M. Zubretsky sold 87,500 shares of the firm's stock in a transaction on Wednesday, April 30th. The stock was sold at an average price of $320.06, for a total transaction of $28,005,250.00. Following the completion of the transaction, the chief executive officer directly owned 257,715 shares in the company, valued at $82,484,262.90. This trade represents a 25.35% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Richard M. Schapiro sold 669 shares of the business's stock in a transaction on Tuesday, April 29th. The shares were sold at an average price of $320.50, for a total value of $214,414.50. Following the completion of the sale, the director owned 11,244 shares in the company, valued at $3,603,702. This represents a 5.62% decrease in their position. The disclosure for this sale can be found here. 1.10% of the stock is owned by company insiders.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.